Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 17/20 | 0.43 |
| ▸ | PPARG | P37231 | 16/20 | 0.43 |
| ▸ | PPARD | Q03181 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5225901 | 0.84 | PPARA (0.41) | PPARAPPARGPPARDKDM4EALDH1A1 | |
| SCHEMBL5229122 | 0.81 | PPARA (0.55) | PPARAPPARG | |
| SCHEMBL5428687 | 0.78 | PPARA (0.42) | PPARAPPARGPPARDKDM4EALDH1A1 | |
| SCHEMBL14361086 | 0.76 | PPARG (0.51) | PPARAPPARGPPARD | |
| SCHEMBL5228263 | 0.74 | PPARA (0.54) | PPARAPPARG | |
| SCHEMBL5441048 | 0.73 | PPARA (0.46) | PPARAPPARGPPARD | |
| SCHEMBL5269968 | 0.73 | PPARA (0.41) | PPARAPPARGPPARD | |
| SCHEMBL5224845 | 0.72 | PPARG (0.52) | PPARAPPARGPPARD | |
| SCHEMBL5256113 | 0.72 | PPARA (0.46) | PPARAPPARGPPARD | |
| SCHEMBL5227383 | 0.71 | PPARG (0.53) | PPARAPPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1778654-A1 | SULFAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR UPREGULATION OF LIPID METABOLISM COMPRISING SAME | Crystalgenomics, Inc. (KR) | 2007-05-02 | — | — | EP | disclosed |
| WO-2006006832-A1 | SULFAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR UPREGULATION OF LIPID METABOLISM COMPRISING SAME | CRYSTALGENOMICS, INC. (KR) | 2006-01-19 | — | — | WO | disclosed |